ContraDyn Overview

  • Founded
  • 2006


  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

ContraDyn General Information


Developer of polymer-drug delivery technology intended to treat tumors. The company's technology offers a nano-globular drug delivery system for targeting tumors and chemotherapeutic agents for treating tumors without invasive surgery, enabling healthcare professionals to treat their patients with minimum pain.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Primary Office
  • 615 Arapeen Drive
  • Suite 102
  • Salt Lake City, UT 84108
  • United States
+1 (801) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ContraDyn Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Dec-2022 00000 Completed Generating Revenue
2. Early Stage VC (Series A1) 01-Jan-2009 00000 00000 00.00 Completed Generating Revenue
1. Grant 01-Jul-2008 $250K Completed Generating Revenue
To view ContraDyn’s complete valuation and funding history, request access »

ContraDyn Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1 000,000 00.000000 00 00 00 00 0.000
To view ContraDyn’s complete cap table history, request access »

ContraDyn Comparisons

HQ Location
Total Raised
Post Valuation
Developer of polymer-drug delivery technology intended to treat tumors. The company's technology offers a nano-globular
Drug Delivery
Salt Lake City, UT
00000000000 00000

00 000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volu
0000 000000000
Irvine, CA
00 As of 0000
0000 0000-00-00
00000000000 00000


eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ve
00000 0000000 000 00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ContraDyn Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CG Oncology Venture Capital-Backed Irvine, CA 00 00000 00000000000 00000
000000000 00000000 Corporate Backed or Acquired Canada 000000&0
You’re viewing 2 of 2 competitors. Get the full list »

ContraDyn Executive Team (1)

Name Title Board Seat Contact Info
Zheng-Rong Lu Ph.D Scientific Founder
To view ContraDyn’s complete executive team members history, request access »

ContraDyn Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
UpStart Ventures (Salt Lake City) Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Utah Centers of Excellence Government 000 0000 000000 0
To view ContraDyn’s complete investors history, request access »